Profile | GDS4284 / 211560_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 5110.46 | 93 |
GSM687648 | Patient 402 control | 12722.5 | 98 |
GSM687653 | Patient 403 control | 929.659 | 73 |
GSM687658 | Patient 404 control | 10552.1 | 97 |
GSM687663 | Patient 411 control | 10848.4 | 97 |
GSM687668 | Patient 422 control | 17102.9 | 98 |
GSM687673 | Patient 424 control | 36836.3 | 99 |
GSM687678 | Patient 425 control | 3233.96 | 89 |
GSM687683 | Patient 427 control | 19294.5 | 99 |
GSM687688 | Patient 428 control | 2588.33 | 87 |
GSM687695 | Patient 441 control | 91487.5 | 99 |
GSM687699 | Patient 443 control | 15533.9 | 98 |
GSM687704 | Patient 444 control | 2748.68 | 88 |
GSM687707 | Patient 448 control | 6191.18 | 95 |
GSM687712 | Patient 449 control | 12614.3 | 98 |
GSM687719 | Patient 450 control | 29067.7 | 99 |
GSM687724 | Patient 451 control | 17797.8 | 98 |
GSM687728 | Patient 452 control | 7158.47 | 96 |
GSM687646 | Patient 401 treated 24h | 2486.05 | 86 |
GSM687649 | Patient 402 treated 24h | 9509.24 | 97 |
GSM687665 | Patient 411 treated 24h | 12781.8 | 98 |
GSM687651 | Patient 402 treated 4 weeks | 12457.7 | 98 |
GSM687667 | Patient 411 treated 4 weeks | 5557.74 | 94 |
GSM687670 | Patient 422 treated 24h | 16135.1 | 98 |
GSM687671 | Patient 422 treated 4 weeks | 15587.5 | 98 |
GSM687654 | Patient 403 treated 24h | 2108.25 | 85 |
GSM687675 | Patient 424 treated 24h | 43541.6 | 99 |
GSM687685 | Patient 427 treated 24h | 20376.7 | 99 |
GSM687656 | Patient 403 treated 4 weeks | 4276.42 | 92 |
GSM687677 | Patient 424 treated 4 weeks | 18650.7 | 99 |
GSM687687 | Patient 427 treated 4 weeks | 2801.72 | 88 |
GSM687692 | Patient 428 treated 4h | 2934.16 | 88 |
GSM687716 | Patient 449 treated 4h | 5873.69 | 94 |
GSM687722 | Patient 450 treated 4h | 32602.2 | 99 |
GSM687680 | Patient 425 treated 24h | 4868.98 | 93 |
GSM687690 | Patient 428 treated 24h | 4006.29 | 91 |
GSM687700 | Patient 443 treated 24h | 35237.7 | 99 |
GSM687705 | Patient 444 treated 24h | 4489.49 | 92 |
GSM687714 | Patient 449 treated 24h | 11582.9 | 97 |
GSM687721 | Patient 450 treated 24h | 53394.9 | 99 |
GSM687682 | Patient 425 treated 4 weeks | 3435.61 | 90 |
GSM687694 | Patient 428 treated 4 weeks | 6327.14 | 95 |
GSM687702 | Patient 443 treated 4 weeks | 12087 | 98 |
GSM687718 | Patient 449 treated 4 weeks | 7561.15 | 96 |
GSM687723 | Patient 450 treated 4 weeks | 19001.5 | 99 |
GSM687661 | Patient 404 treated 4h | 12281.1 | 98 |
GSM687710 | Patient 448 treated 4h | 9934.51 | 97 |
GSM687726 | Patient 451 treated 4h | 16202.8 | 98 |
GSM687730 | Patient 452 treated 4h | 26561.2 | 99 |
GSM687660 | Patient 404 treated 24h | 44596.3 | 99 |
GSM687697 | Patient 441 treated 24h | 50132.4 | 99 |
GSM687709 | Patient 448 treated 24h | 8983.92 | 97 |
GSM687725 | Patient 451 treated 24h | 23924 | 99 |
GSM687729 | Patient 452 treated 24h | 42859.9 | 99 |
GSM687727 | Patient 451 treated 4 weeks | 15633.5 | 98 |
GSM687731 | Patient 452 treated 4 weeks | 3276.57 | 90 |